Association between vitamin D/calcium intake and 25-hydroxyvitamin D and risk of ovarian cancer: A dose-response relationship meta-analysis
J Xu, K Chen, F Zhao, D Huang, H Zhang… - European journal of …, 2021 - nature.com
Background The association between vitamin D/calcium and risk of ovarian cancer is still a
debatable point. The aim of our study was to systematically investigate the association …
debatable point. The aim of our study was to systematically investigate the association …
Progress in research and development of temozolomide brain-targeted preparations: A review
J Yang, Y Xu, Z Fu, J Chen, W Fan… - Journal of Drug Targeting, 2023 - Taylor & Francis
Gliomas are a heterogeneous group of brain tumours with high malignancy, for which
surgical resection remains the mainstay of treatment at present. However, the overall …
surgical resection remains the mainstay of treatment at present. However, the overall …
Low-dose mono (2-ethylhexyl) phthalate promotes ovarian cancer development through PPARα-dependent PI3K/Akt/NF-κB pathway
J Leng, H Li, Y Niu, K Chen, X Yuan, H Chen… - Science of The Total …, 2021 - Elsevier
Abstract The plasticizer di (2-ethylhexyl) phthalate (DEHP) and its hydrolysate mono (2-
ethylhexyl) phthalate (MEHP) are major toxicants from plastics, but their association with …
ethylhexyl) phthalate (MEHP) are major toxicants from plastics, but their association with …
[HTML][HTML] MAP4K4 promotes ovarian cancer metastasis through diminishing ADAM10-dependent N-cadherin cleavage
K Chen, X Yuan, S Wang, F Zheng, Z Fu, Z Shen… - Oncogene, 2023 - nature.com
Peritoneal metastasis is a key feature of advanced ovarian cancer, but the critical protein
required for ovarian cancer metastasis and progression is yet to be defined. Thus, an …
required for ovarian cancer metastasis and progression is yet to be defined. Thus, an …
Low dose of bisphenol a modulates ovarian cancer gene expression profile and promotes epithelial to mesenchymal transition via canonical wnt pathway
The xenoestrogen bisphenol A (BPA) is a synthetic endocrine disrupting chemical, having
the potential to increase the risk of hormone-dependent ovarian cancer. Thus, a deeper …
the potential to increase the risk of hormone-dependent ovarian cancer. Thus, a deeper …
Prognostic value of phospho‐Akt in patients with non‐small cell lung carcinoma: A meta‐analysis
Y Yang, J Luo, X Zhai, Z Fu, Z Tang… - … journal of cancer, 2014 - Wiley Online Library
Previous studies have been inconsistent with respect to the reported associations between
phospho‐Akt (p‐Akt) overexpression and lung cancer prognosis. In this study, we conducted …
phospho‐Akt (p‐Akt) overexpression and lung cancer prognosis. In this study, we conducted …
Association between urinary phthalate metabolites and risk of breast cancer and uterine leiomyoma
Z Fu, F Zhao, K Chen, J Xu, P Li, D Xia, Y Wu - Reproductive Toxicology, 2017 - Elsevier
Objective The objective of this study was to systematically assess the association between
urinary phthalate metabolites and risk of breast cancer and uterine leiomyoma. Methods …
urinary phthalate metabolites and risk of breast cancer and uterine leiomyoma. Methods …
[HTML][HTML] LncRNA CASC15, MiR-23b cluster and SMAD3 form a novel positive feedback loop to promote epithelial-mesenchymal transition and metastasis in ovarian …
H Lin, X Xu, K Chen, Z Fu, S Wang, Y Chen… - … Journal of Biological …, 2022 - ncbi.nlm.nih.gov
Abstract Cancer Susceptibility Candidate 15 (CASC15), which is a newly identified long
noncoding RNA crucial for epigenetic regulation in human tumors, was found to be …
noncoding RNA crucial for epigenetic regulation in human tumors, was found to be …
A novel drug delivery carrier comprised of nimodipine drug solution and a nanoemulsion: preparation, characterization, in vitro, and in vivo studies
S Huang, Z Huang, Z Fu, Y Shi, Q Dai… - International Journal …, 2020 - Taylor & Francis
Purpose Nimodipine (NIMO) is used clinically to treat ischemic damage resulting from
subarachnoid hemorrhage. However, clinical application of NIMO is limited by poor aqueous …
subarachnoid hemorrhage. However, clinical application of NIMO is limited by poor aqueous …
Inhibition of cervical cancer cell growth in vitro and in vivo by lentiviral-vector mediated shRNA targeting the common promoter of HPV16 E6 and E7 oncogenes
J Zhou, B Li, C Peng, F Wang, Z Fu, C Zhou, D Hong… - Antiviral research, 2013 - Elsevier
Deregulated expression of high-risk human papillomavirus oncogenes (E6 and E7) is a
pivotal event for pathogenesis and progression in cervical cancer. Both viral oncogenes are …
pivotal event for pathogenesis and progression in cervical cancer. Both viral oncogenes are …